United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read Healthcare Industry News Maypharm introduces SkinColla: The first recombinant human collagen filler transforming skin rejuvenation Maypharm Co., Ltd. has unveiled SkinColla, a breakthrough in skin rejuvenation technology that leverages recombinant human collagen filler… byPallavi MadhirajuFebruary 17, 2025